JPRN-jRCTs051180233招募中2 期
Phase II study of multidisciplinary therapy of pediatric intracranial ependymoma with risk classification by postoperative residual tumor size and histological malignancy. - JCCG EPN1501
Sakamoto Hiroaki0 个研究点目标入组 40 人开始时间: 2019年3月30日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 3age old 至 < 20age old（—）
- 性别
- All
入选标准
- •Newly developed intracranial ependymoma, from 3 years old to under 20 years old (no seeding metastatic lesions)
排除标准
- •Exclude those subject to any of the following conditions.
- •1) Active duplication cancers (simultaneous duplicated cancers and metachronous duplicated cancers with disease-free period within 5 years).
- •2) Heart disease with treatment is merged.
- •3) Pregnant or lactating women
- •4) When judging that the doctor in charge is inappropriate
研究者
相似试验
进行中（未招募）
2 期
WJOG11118JPRN-jRCTs041200046Hirotsugu Kenmotsu30
进行中（未招募）
不适用
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
已完成
2 期
A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung canceron-small cell lung cancerJPRN-UMIN000029435Department of respiratory medicine, Kurashiki Central Hospital20
招募中
2 期
A Phase 2 Trial of Multimodal Treatment based on VDC-IE with Interval Compressed Schedule by using G-CSF for Patients with Non-metastatic Ewing Sarcoma Family Tumoron-metastatic Ewing Sarcoma Family TumorJPRN-UMIN000020903Japan Ewing Sarcoma Study Group66
招募中
2 期
JESS14Ewing sarcoma family tumorC04.557.450.565.575.650.800Ewing sarcomaJPRN-jRCTs021180022Sano Hideki66